This session, presented by Dr. Fabio Garofolo, Vice-President Bioanalytical Services, Algorithme Pharma at the 2014 SOT Annual Meeting, focuses on methods to overcome limitations of Dried Blood Spot analysis and highlights the Pre-Cut technique for use in analyzing New Molecular Entities and Biomarkers. It also includes the recent IQ recommendations on refining DBS to meet regulatory requirements. Participants are provided with an overview of key points to consider for DBS analysis and what is required for regulatory agency acceptance. This session includes key scientific insights on the following DBS issues: hematocrit impact, dilution effect, internal standard techniques & stability considerations.
Click on the link below to request the complete presentation slides.